BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9919348)

  • 1. The Polarprobe--emerging technology for cervical cancer screening.
    Quek SC; Mould T; Canfell K; Singer A; Skladnev V; Coppleson M
    Ann Acad Med Singap; 1998 Sep; 27(5):717-21. PubMed ID: 9919348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for cervical cancer by Pap smear.
    Rizvi JH; Hasan S; Rasul S; Ghazali B; Jamal A
    J Pak Med Assoc; 1988 Sep; 38(9):229-31. PubMed ID: 3149319
    [No Abstract]   [Full Text] [Related]  

  • 3. Stanley F. Patten, Jr., M.D., Ph.D. and the development of an automated Papanicolaou smear screening system.
    Lee JS; Nelson AC
    Cancer; 1997 Dec; 81(6):332-6. PubMed ID: 9438457
    [No Abstract]   [Full Text] [Related]  

  • 4. Risk of cervical cancer after a negative Pap smear.
    Viikki M; Pukkala E; Hakama M
    J Med Screen; 1999; 6(2):103-7. PubMed ID: 10444730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.
    Nygård JF; Skare GB; Thoresen SØ
    J Med Screen; 2002; 9(2):86-91. PubMed ID: 12133929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Papanicolaou smear screening and cervical cancer. What can you expect?
    Stenkvist B; Bergström R; Eklund G; Fox CH
    JAMA; 1984 Sep; 252(11):1423-6. PubMed ID: 6471269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The costs, clinical benefits, and cost-effectiveness of screening for cervical cancer in HIV-infected women.
    Goldie SJ; Weinstein MC; Kuntz KM; Freedberg KA
    Ann Intern Med; 1999 Jan; 130(2):97-107. PubMed ID: 10068381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The coverage of cervical cancer screening in Khon Kaen, northeast Thailand.
    Kritpetcharat O; Suwanrungruang K; Sriamporn S; Kamsa-Ard S; Kritpetcharat P; Pengsaa P
    Asian Pac J Cancer Prev; 2003; 4(2):103-5. PubMed ID: 12875621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current use of the Papanicolaou smear.
    Crump WJ
    J Am Board Fam Pract; 1988; 1(2):131-4. PubMed ID: 3414395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Papanicolaou smear: can we make a good test better? Technical and interpretive challenges for the practitioner.
    Eltabbakh GH; Eltabbakh GD
    J Womens Health Gend Based Med; 1999 May; 8(4):469-76. PubMed ID: 10839701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical cancer screening in Santiago Atitlán, Guatemala.
    Frey MK; Roselli N; Gertz E; Cuc JC; Boyd L; Shirazian T
    Int J Gynaecol Obstet; 2016 Oct; 135(1):119. PubMed ID: 27451397
    [No Abstract]   [Full Text] [Related]  

  • 12. Incidence of cervical cancer following negative smear. A cohort study from Maribo County, Denmark.
    Lynge E; Poll P
    Am J Epidemiol; 1986 Sep; 124(3):345-52. PubMed ID: 3740035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical cancer screening among low-income women: results of a national screening program, 1991-1995.
    Lawson HW; Lee NC; Thames SF; Henson R; Miller DS
    Obstet Gynecol; 1998 Nov; 92(5):745-52. PubMed ID: 9794662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liquid based cytology: a new cervical screening system for the UK.
    Wall A
    J Fam Health Care; 2005; 15(3):90-2. PubMed ID: 16094904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The preparation of additional smears from a cervical scrape: impact on the rate of detection of cervical neoplasia.
    Al-Awadhi R; Byrne M; Coleman DV
    Cytopathology; 2001 Jun; 12(3):151-6. PubMed ID: 11380556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cervical cancer screening from Pap smear to human papillomavirus DNA testing.
    Jin XW; Xu H
    Compr Ther; 2001; 27(3):202-8. PubMed ID: 11569320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A decade has passed...the Pap smear and cervical cancer.
    Linder J
    Am J Clin Pathol; 1997 Nov; 108(5):492-8. PubMed ID: 9353086
    [No Abstract]   [Full Text] [Related]  

  • 18. Point of care testing: can it be a solution for cervical cancer prevention?
    Wiwanitkit V
    Asian Pac J Cancer Prev; 2010; 11(2):575-6. PubMed ID: 20843156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No increased risk for cervical cancer after a broader definition of a negative Pap smear.
    Rebolj M; van Ballegooijen M; van Kemenade F; Looman C; Boer R; Habbema JD
    Int J Cancer; 2008 Dec; 123(11):2632-5. PubMed ID: 18767046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for cervical cancer by Pap smear.
    Rehan N
    J Pak Med Assoc; 1989 Apr; 39(4):116-8. PubMed ID: 2501528
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.